KORU Medical Systems, Inc.
KRMDUS売上高
$41M
百万USD
営業利益
$-3M
百万USD
純利益
$-3M
百万USD
ROE
-15.5%
最新FY
EPS
$-0.06
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $5M | $-1M | $-0.03 |
| FY2021 | Q2 | $6M | $-1M | $-0.03 |
| FY2021 | Q3 | $6M | $-1M | $-0.02 |
| FY2021 | FY | $23M | $-5M | $-0.10 |
| FY2022 | Q1 | $6M | $-3M | $-0.06 |
| FY2022 | Q2 | $7M | $-3M | $-0.07 |
| FY2022 | Q3 | $8M | $-1M | $-0.03 |
| FY2022 | FY | $28M | $-9M | $-0.19 |
| FY2023 | Q1 | $7M | $-2M | $-0.05 |
| FY2023 | Q2 | $7M | $-2M | $-0.05 |
| FY2023 | Q3 | $7M | $-1M | $-0.03 |
| FY2023 | FY | $29M | $-14M | $-0.30 |
| FY2024 | Q1 | $8M | $-2M | $-0.04 |
| FY2024 | Q2 | $8M | $-1M | $-0.02 |
| FY2024 | Q3 | $8M | $-2M | $-0.03 |
| FY2024 | FY | $34M | $-6M | $-0.13 |
| FY2025 | Q1 | $10M | $-1M | $0.03 |
| FY2025 | Q2 | $10M | $-0M | $0.00 |
| FY2025 | Q3 | $10M | $-1M | $0.02 |
| FY2025 | FY | $41M | $-3M | $-0.06 |
| FY2026 | Q1 | $12M | $-1M | $-0.02 |
財務データ
| 指標 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $23M | $24M | $23M | $28M | $29M | $34M | $41M |
| 営業利益 | $-1M | $1M | $1M | $-1M | $-7M | $-11M | $-10M | $-6M | $-3M |
| 純利益 | $-1M | $1M | $1M | $-1M | $-5M | $-9M | $-14M | $-6M | $-3M |
| 総資産 | $8M | $11M | $14M | $40M | $41M | $42M | $28M | $27M | $28M |
| 純資産 | - | - | - | - | - | - | - | - | - |
| 自己資本 | $7M | $9M | $11M | $36M | $37M | $31M | $20M | $17M | $17M |
| 営業CF | - | $1M | $0M | $-1M | $-4M | $-5M | $-5M | $-0M | $0M |
| EPS | $-0.01 | $0.02 | $0.01 | $-0.03 | $-0.10 | $-0.19 | $-0.30 | $-0.13 | $-0.06 |
| BPS | $0.18 | $0.23 | $0.28 | $0.81 | $0.82 | $0.69 | $0.45 | $0.37 | $0.37 |
| ROE | -8.0% | 10.2% | 5.0% | -3.4% | -12.5% | -27.6% | -67.5% | -36.1% | -15.5% |